Pharmacokinetic interaction between tamoxifen and ondansetron in rats: non-competitive (hepatic) and competitive (intestinal) inhibition of tamoxifen metabolism by ondansetron via CYP2D subfamily and 3A1/2 Si Hyung YangJung Hwa SuhMyung Gull Lee Original Article 06 June 2009 Pages: 407 - 418
Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primates Jodi A. MuscalPatrick A. ThompsonJack M. Su Original Article 13 June 2009 Pages: 419 - 425
Protein kinase inhibitors emodin and dichloro-ribofuranosylbenzimidazole modulate the cellular accumulation and cytotoxicity of cisplatin in a schedule-dependent manner Tetsuji KurokawaGuangan HeZahid H. Siddik Original Article 16 June 2009 Pages: 427 - 436
MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer Ning SunXinchen SunZuhong Lu Original Article Open access 01 July 2009 Pages: 437 - 446
Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins Özlem Darcansoy IşeriMeltem Demirel KarsUfuk Gündüz Original Article 19 June 2009 Pages: 447 - 455
Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer Yago NietoJosé Manuel AramendíaFernando Martínez Regueira Original Article 14 June 2009 Pages: 457 - 465
Effects of bevacizumab on plasma concentration of irinotecan and its metabolites in advanced colorectal cancer patients receiving FOLFIRI with bevacizumab as second-line chemotherapy Yosuke HoritaY. YamadaY. Shimada Original Article 25 June 2009 Pages: 467 - 471
Phase I/II and pharmacokinetic study of S-1 and oxaliplatin in previously untreated advanced gastric cancer Inkeun ParkJae-Lyun LeeYoon-Koo Kang Original Article 24 June 2009 Pages: 473 - 480
Synergistic effect of 5-fluorouracil and the flavanoid oroxylin A on HepG2 human hepatocellular carcinoma and on H22 transplanted mice Li ZhaoZhen ChenQing-Long Guo Original Article 08 July 2009 Pages: 481 - 489
Ambulatory administration of 5-day infusion ifosfamide + mesna: a pilot study in sarcoma patients Romain CoriatOlivier MirFrançois Goldwasser Original Article 09 July 2009 Pages: 491 - 495
A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer Atul SharmaBidhu MohantiGoura Rath Original Article 03 July 2009 Pages: 497 - 502
Multicenter phase 2 study of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma Hiroshi KuritaEtsuhide YamamotoKenji Kurashina Original Article 05 July 2009 Pages: 503 - 508
A phase II study of oxaliplatin, docetaxel, and GM-CSF in patients with previously treated advanced melanoma Frederick LockeJoseph I. ClarkThomas F. Gajewski Original Article 12 July 2009 Pages: 509 - 514
Pharmacokinetics and tissue distribution of PGG–paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenografts Xinghe WangGang ZhaoStephen B. Howell Original Article Open access 11 July 2009 Pages: 515 - 526
A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer Do-Youn OhYongjun ChaYeul Hong Kim Original Article 04 July 2009 Pages: 527 - 536
Inclusion complexes of noscapine in β-cyclodextrin offer better solubility and improved pharmacokinetics Jitender MadanNeerupma DhimanAnju Katyal Original Article 14 July 2009 Pages: 537 - 548
Effects of cyclooxygenase inhibitor treatment on the renal toxicity of cisplatin in rats Shawna N. GreeneJosé A. Ramos-VaraDeborah W. Knapp Original Article 23 July 2009 Pages: 549 - 556
A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer Susan F. DentStan GertlerNeill Iscoe Original Article 11 July 2009 Pages: 557 - 561
Effect of rifampin on the pharmacokinetics of Axitinib (AG-013736) in Japanese and Caucasian healthy volunteers Y. K. PithavalaM. TortoriciK. J. Klamerus Original Article Open access 15 July 2009 Pages: 563 - 570
Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOP Yee Soo ChaeJong Gwang KimMyung-Hoon Lee Original Article 24 July 2009 Pages: 571 - 577
Predictive factors for the efficacy of cetuximab plus chemotherapy as salvage therapy in metastatic gastric cancer patients Sook Ryun ParkMyeong-Cherl KookNoe Kyeong Kim Original Article 24 July 2009 Pages: 579 - 587
Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer Woo Kyun BaeJun Eul HwangIk-Joo Chung Original Article 15 October 2009 Pages: 589 - 595
Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer Mohammad H. PourgholamiMichael SzwajcerMatthew Links Clinical Trial Report 11 November 2009 Pages: 597 - 605
Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma Flávio Henrique Ferreira GalvãoJosé Osmar Medina PestanaVera Luiza Capelozzi Short Communication Open access 11 November 2009 Pages: 607 - 610
